The major goal in vaccination is establishment of long-term, prophylactic humoral memory to a pathogen.Two major components to long-lived humoral memory are plasma cells for the production of specific immunoglobulin and memory B cells that survey for their specific antigen in the periphery for later affinity maturation, proliferation, and differentiation. The study of human B cell memory has been aided by the discovery of a general marker for B cell memory, expression of CD27; however, new data suggests the existence of CD27- memory B cells as well.These recently described non-canonical memory populations have increasingly pointed to the heterogeneity of the memory compartment. The novel B memory subsets in humans appear to have unique origins, localization, and functions compared to what was considered to be a "classical" memory B cell. In this article, we review the known B cell memory subsets, the establishment of B cell memory in vaccination and infection, and how understanding these newly described subsets can inform vaccine design and disease treatment. © 2011 Pauli, Henry Dunand and Wilson. This is an open-access.
CITATION STYLE
Pauli, N. T., Henry Dunand, C. J., & Wilson, P. C. (2011). Exploiting human memory B cell heterogeneity for improved vaccine efficacy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2011.00077
Mendeley helps you to discover research relevant for your work.